Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NuGen Medical Devices Inc (TSE:NGMD)
TSXV:NGMD
Holding TSE:NGMD?
Track your performance easily
NGMD Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.08 - C$0.16
Previous CloseC$0.1
Volume794.82K
Average Volume (3M)319.97K
Market Cap
C$18.99M
Enterprise ValueC$27.05M
Total Cash (Recent Filing)C$172.92K
Total Debt (Recent Filing)C$8.24M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding216,425,682
10 Day Avg. Volume258,625
30 Day Avg. Volume319,972
Standard Deviation0.35
R-Squared0.09
Alpha-0.00237
Financial Highlights & Ratios
Price to Book (P/B)-6.00
Price to Sales (P/S)157.26
Price to Cash Flow (P/CF)-24.00
P/FCF Ratio46.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NuGen Medical Devices Inc News
PremiumCompany Announcements
NuGen’s Q2 Report Signals Strong Future Prospects
PremiumCompany Announcements
NuGen Shareholders Approve All Resolutions with Strong Support
PremiumCompany Announcements
NuGen Revises Terms for $10 Million Private Placement
PremiumCompany Announcements
NuGen Secures Major Repeat Order in Mexico
PremiumCompany Announcements
NuGen Targets $10M Raise for Expansion Efforts
PremiumCompany Announcements
NuGen Partners to Train Pharmacists in CanadaPremiumCompany Announcements
NuGen Readies for InsuJet™ Launch in BrazilPremiumCompany Announcements
NuGen Sees Growing Demand for InsuJet in YemenOptions Prices
Currently, No data available
---
Ownership Overview
8.83% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.17% Public Companies and
Individual Investors
NGMD FAQ
What was NuGen Medical Devices Inc’s price range in the past 12 months?
NuGen Medical Devices Inc lowest stock price was C$0.08 and its highest was C$0.15 in the past 12 months.
What is NuGen Medical Devices Inc’s market cap?
Currently, no data Available
When is NuGen Medical Devices Inc’s upcoming earnings report date?
NuGen Medical Devices Inc’s upcoming earnings report date is Nov 27, 2024 which is in 68 days.
How were NuGen Medical Devices Inc’s earnings last quarter?
NuGen Medical Devices Inc released its earnings results on Aug 29, 2024. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is NuGen Medical Devices Inc overvalued?
According to Wall Street analysts NuGen Medical Devices Inc’s price is currently Overvalued.
Does NuGen Medical Devices Inc pay dividends?
NuGen Medical Devices Inc does not currently pay dividends.
What is NuGen Medical Devices Inc’s EPS estimate?
NuGen Medical Devices Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NuGen Medical Devices Inc have?
NuGen Medical Devices Inc has 199,843,120 shares outstanding.
What happened to NuGen Medical Devices Inc’s price movement after its last earnings report?
NuGen Medical Devices Inc reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NuGen Medical Devices Inc?
Currently, no hedge funds are holding shares in TSE:NGMD
---
NuGen Medical Devices Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.39%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-30.42%
Trailing 12-Months
Company Description
NuGen Medical Devices Inc
NuGen Medical Devices Inc is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. Its principal business is the research, development and commercialization of innovative needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using needlefree drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anaemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis as well as DNA and conventional/pediatric vaccines.
---
Technical Analysis
---